Revenue
$5.32B
Fiscal year ended 2026-06-30Operating income
$323.00M
Fiscal year ended 2026-06-30Free cash flow
$137.00M
Fiscal year ended 2026-06-30Bausch & Lomb Corp (BLCO) reported revenue of $5.32B and net income of -$171.00M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Bausch & Lomb Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Ophthalmic Goods.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $5.32B |
| Cost of revenue | Unavailable |
| Gross profit | Unavailable |
| Operating income | $323.00M |
| Net income | -$171.00M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | -$65.00M |
| Income tax expense | $98.00M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $2.22B |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $367.00M |
| Total assets | $13.86B |
| Current assets | $2.92B |
| Total liabilities | $7.42B |
| Current liabilities | $1.89B |
| Total equity incl. NCI | $6.44B |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $999.00M |
| Accounts receivable | $1.16B |
| Goodwill | $4.72B |
| Long-term debt | $5.05B |
| Accounts payable | $426.00M |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $458.00M |
| Capital expenditures | $321.00M |
| Investing cash flow | -$466.00M |
| Financing cash flow | $118.00M |
| Net change in cash | $106.00M |
| Stock-based compensation | $163.00M |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | $411.00M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | $137.00M |
| Gross margin | Unavailable |
| Operating margin | 6.1% |
| FCF margin | 2.6% |
| SBC / revenue | 3.1% |
| Current ratio | 1.55x |
| Revenue YoY growth | 8.9% |
| Net margin | -3.2% |
| R&D / revenue | Unavailable |
| CapEx / revenue | 6.0% |
| Long-term debt / equity | 0.78x |
| Effective tax rate | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BLCO in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-29View SEC filing
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-30View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.